M

Magnolia Neurosciences

10 employees

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Health Care
neuroprotective
neurodegenerative
Wellness
small molecule therapeutics

Date founded

2018

Funding rounds raised

Total raised

$31M

from 5 investors over 5 rounds

M

Magnolia Neurosciences raised $31M on August 13, 2018

Investors: Lilly Asia Ventures, WATSON FUND, L.P., MD Anderson Cancer Center, ARCH Venture Partners and WuXi AppTec

FAQ